Sitero Expands Clinical AI Across the Data Lifecycle

Coral Gables, Florida, August 18, 2026

SiteroAI Creates a GxP-Ready Data Foundation

The three Ash workflows operate on SiteroAI, Sitero’s clinical intelligence engine designed to consolidate and harmonize information from across the clinical trial ecosystem. The platform can ingest data from electronic data capture (EDC), interactive response technology (IRT/RTSM), central and local laboratories, ePRO systems, safety databases, and third-party vendors into a governed data layer. By providing Ash with a unified and current view of study information, Sitero aims to reduce data fragmentation while improving the context and traceability of AI-generated insights. Each workflow follows a common governance framework that includes human review at every decision gate, study-specific source-data grounding, permission-aware access controls, and a complete audit trail. Sitero emphasizes that Ash does not independently make clinical, safety, or quality decisions, keeping qualified human teams responsible for critical decisions within regulated clinical research environments.

AI Accelerates Study Configuration and Data Management

Ash for Study Configuration is designed to accelerate the transition from protocol upload to a fully configured study. Sitero says clinical teams can receive a structured study draft containing the study tree, visits, forms, fields, codelists, and edit checks, drawing on protocol and standards libraries. Configuration documentation, including annotated CRFs, edit-check specifications, data management plans, and amendment histories, can be maintained through integrated eBinders with version control and audit-ready organization. Electronic signature workflows are also designed to simplify review and approval. When protocols change, Ash can identify downstream impacts, route updated specifications for review, and update relevant documentation, potentially reducing study-change processes from weeks to days. The company says this approach can help sponsors open enrollment sooner and manage protocol amendments more efficiently. Ash for Data Management focuses on continuous data review, query management, and vendor reconciliation. In an early deployment with a top-ten pharmaceutical company, Sitero reports that the workflow delivered more than 180 data review program checks in approximately five weeks, compared with an estimated three to four months using traditional SAS-based approaches, representing approximately 75% faster execution. Its DM Workbench provides role-based review assignments based on factors such as data type, therapeutic area, and team structure, while the Clean Patient Tracker provides subject-level visibility into patient readiness, open blockers, and query history. The platform logs each check in an audit trail, allowing data teams to identify issues as they emerge instead of waiting for scheduled review cycles.

Clinical Insights and Portfolio Risk Visibility

Ash for Insights provides continuous study and portfolio-level visibility, including database lock forecasting, clean-patient tracking, query trends, and lock readiness. Clinical operations teams and leadership can view multiple concurrent studies through a consolidated dashboard, helping them monitor trial health and identify potential risks without relying solely on end-of-study reporting. Sitero is also developing additional AI capabilities, including Ash for SDTM automation, Ash for Medical Monitoring, and Ash for Risk-Based Quality Management (RBQM). Together, the expanded workflows demonstrate Sitero’s strategy of applying agentic AI to regulated clinical research workflows while maintaining governance, security, data lifecycle controls, and human accountability. The development highlights the growing adoption of AI technologies designed specifically for clinical trials, clinical data management, GxP compliance, and pharmaceutical research operations.

Source: Sitero press relese